Ghrelin ameliorates intestinal barrier dysfunction in experimental colitis by inhibiting the activation of nuclear factor-kappa B

2015 ◽  
Vol 458 (1) ◽  
pp. 140-147 ◽  
Author(s):  
Jian Cheng ◽  
Lin Zhang ◽  
Weiqi Dai ◽  
Yuqing Mao ◽  
Sainan Li ◽  
...  
Keyword(s):  
Nuclear Factor Kappa B ◽  
Intestinal Barrier ◽  
Experimental Colitis ◽  
Nuclear Factor ◽  
Barrier Dysfunction ◽  
Intestinal Barrier Dysfunction ◽  
Nuclear Factor Kappa

scholarly journals Pioglitazone Attenuates Experimental Colitis-Associated Hyperalgesia through Improving the Intestinal Barrier Dysfunction

Inflammation ◽  
2020 ◽  
Vol 43 (2) ◽  
pp. 568-578
Author(s):  
Yulin Huang ◽  
Chenchen Wang ◽  
Xinyu Tian ◽  
Yanting Mao ◽  
Bailin Hou ◽  
...  
Keyword(s):  
Intestinal Barrier ◽  
Experimental Colitis ◽  
Barrier Dysfunction ◽  
Intestinal Barrier Dysfunction

Mo1699 Denosumab: A Monoclonal Antibody to Receptor Activator of Nuclear Factor-Kappa B Ligand (RANKL) Decreases Experimental Colitis

2015 ◽  
Vol 148 (4) ◽  
pp. S-688-S-689
Author(s):  
Azin Khafipour ◽  
Peris M. Munyaka ◽  
Hongxing Wang ◽  
Nour Eissa ◽  
Charles N. Bernstein ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Nuclear Factor Kappa B ◽  
Experimental Colitis ◽  
Nuclear Factor ◽  
Nuclear Factor Kappa ◽  
Receptor Activator
Sign in / Sign up

Export Citation Format

Share Document